Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Clinical Trials Using Lomustine

Review the clinical trials studying lomustine on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-12 of 12

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma
Status: Active
Location: 390 locations
Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) versus Standard of Care (Lomustine) for the Treatment of Patients with Recurrent Glioblastoma
Status: Active
Location: 219 locations
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Status: Active
Location: 93 locations
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Status: Active
Location: 30 locations
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
Status: Active
Location: 16 locations
A Study with L19TNF in Combination with Lomustine in Patients with Glioblastoma At Progression or Recurrence
Status: Active
Location: 3 locations
Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG
Status: Active
Location: 6 locations
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
Status: Active
Location: 2 locations
Imipramine Hydrochloride and Lomustine for the Treatment of Recurrent Glioblastoma
Status: Active
Location: Cancer Therapy and Research Center at The UT Health Science Center at San Antonio, San Antonio, Texas
Lerapolturev versus Lomustine for the Treatment of Recurrent GBM
Status: Active
Location: Duke University Medical Center, Durham, North Carolina
A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Laser Interstitial Thermal Therapy Followed by Lomustine for the Treatment of Recurrent Glioblastoma
Status: Active
Location: University of California Davis Comprehensive Cancer Center, Sacramento, California